Once-Daily High-Dose Pindolol for Paroxetine-Refractory Premature Ejaculation: A Double-Blind, Placebo-Controlled and Randomized Study

@article{Safarinejad2008OnceDailyHP,
  title={Once-Daily High-Dose Pindolol for Paroxetine-Refractory Premature Ejaculation: A Double-Blind, Placebo-Controlled and Randomized Study},
  author={Mohammad Reza Safarinejad},
  journal={Journal of Clinical Psychopharmacology},
  year={2008},
  volume={28},
  pages={39-44}
}
  • M. Safarinejad
  • Published 1 February 2008
  • Psychology, Medicine
  • Journal of Clinical Psychopharmacology
Purpose: To evaluate the efficacy and safety of pindolol 7.5 mg/d in delaying of ejaculation in paroxetine-refractory patients. Materials and Methods: Eighty-six married men (mean age, 33 years) with premature ejaculation unresponsive to paroxetine 20 mg/d given for 2 months or longer were randomized to receive 7.5 mg pindolol (n = 44) (group 1) (PXT + POL) or placebo (n = 42) (group 2) (PXT + PBO) for 6 weeks, while continuing paroxetine. After 6 weeks, all patients received paroxetine and… 
The Efficacy and Safety of On-demand Tramadol and Paroxetine Use in Treatment of Life Long Premature Ejaculation: A Randomized Double-blind Placebo-controlled Clinical Trial
TLDR
Tramadol may be considered as an appropriate alternative therapeutic option for lifelong PE after an increase in mean IELT and PEP scores in all 3 groups, and the rate of improvement in tramadol group was significantly more than the others.
Current Diagnosis and Management of Premature Ejaculation
Premature ejaculation (PE) is a common sexual dysfunction characterized by reduced intravaginal ejaculatory latency time (IELT), inability to delay ejaculation, and personal distress. Increasing
Dapoxetine for Premature Ejaculation
TLDR
The lack of ejaculatory control is consistent among all clinical definitions of PE and is a highly sensitive predictor of the condition.
Complementary, Surgical, and Experimental Modalities for Management of Premature Ejaculation
TLDR
The majority of clinical research to date has focused on the condition now most clearly understood as lifelong PE, and there has been a recent movement towards subclassification of early ejaculation into four separate conditions.
‘Up and coming’ treatments for premature ejaculation: progress towards an approved therapy
TLDR
A number of emerging therapies in various stages of development that show potential for use in the treatment of PE are reviewed, which may prove to offer the most favourable risk: benefit profile as well as the flexibility to adapt to differing frequencies of sexual activity.
Premature ejaculation: focus on therapeutic targets
TLDR
There are many targets for future therapeutic approaches to PE that may address the shortcomings of existing therapy, but selecting the best targets depends heavily on their playing a prominent role in PE.
New Concepts in the Diagnosis and Treatment of Premature Ejaculation
TLDR
Emerging medications and the ability to tailor treatments based on genetic information likely will change the paradigm of this disorder and how it will be treated by clinicians.
Further definition on the multiple partner choice arena: a potential animal model for the study of premature ejaculation.
TLDR
The results obtained in the MPCA support its use as an animal model for PE evaluation and the possible participation of the serotoninergic system in the faster ejaculation exhibited by male rats in theMPCA.
A systematic review and meta‐analysis of randomized controlled trials of “on‑demand” use of tramadol vs “on‑demand” use of paroxetine in the management of patients with premature ejaculation
To evaluate the effect of “on‑demand” use of tramadol vs “on‑demand” use of paroxetine in the management of patients with premature ejaculation (PE).
In search for animal models of female sexual dysfunction
Female Sexual Dysfunction (FSD) is a disorder that affects around 40% of the population. Low sexual arousal and low sexual desire are the most common problems. The mechanisms underlying the disorder
...
1
2
3
...

References

SHOWING 1-10 OF 24 REFERENCES
Safety and Efficacy of Escitalopram in the Treatment of Premature Ejaculation: A Double-Blind, Placebo-Controlled, Fixed-Dose, Randomized Study
  • M. Safarinejad
  • Psychology, Medicine
    Journal of clinical psychopharmacology
  • 2006
TLDR
Oral escitalopram is an effective treatment for PE with long-term benefit for the patient after it is withdrawn, and further studies are required to draw final conclusions on the efficacy of this drug in PE.
Tramadol HCL has promise in on-demand use to treat premature ejaculation.
TLDR
Tramadol, a drug with a proven safety record as an anti-inflammatory agent, shows promise as a drug for treating rapid ejaculation.
Short-term analysis of the effects of as needed use of sertraline at 5 PM for the treatment of premature ejaculation.
TLDR
If the results are supported by additional long-term clinical studies, self-therapy with sertraline taken PRN at 5 PM for the treatment of premature ejaculation could be as attractive as self-injection therapy for the Treatment of erectile dysfunction.
Effectiveness of pindolol with selected antidepressant drugs in the treatment of major depression.
TLDR
The results of these studies indicate that pindolol is safe when used in combination with an SSRI or moclobemide and should be tested under double-blind conditions to establish its efficacy.
Relevance of methodological design for the interpretation of efficacy of drug treatment of premature ejaculation: a systematic review and meta-analysis
TLDR
At daily treatment, the overall efficacy of paroxetine, clomipramine, sertraline and fluoxetines is comparable, but paroxettine exerts the strongest ejaculation delay.
Augmentation of Fluoxetine's Antidepressant Action by Pindolol: Analysis of Clinical, Pharmacokinetic, and Methodologic Factors
TLDR
A reanalysis of the data using a survival analysis revealed that significant differences in the time to sustained response between both groups would have also been detected in a 2-week trial, without a placebo lead-in phase, and with less frequent visits, emphasizing the need of using stringent outcome criteria in antidepressant drug trials.
A review of controlled trials in the pharmacological treatment of premature ejaculation.
TLDR
There is a need for quality comparative trial of behavioural therapy, topical anaesthetic agents and antidepressants, including appropriate measures of relapse, follow-up and acceptability of continuing long-term treatment.
Selective Serotonin-Reuptake Inhibitors in the Treatment of Premature Ejaculation
TLDR
Convenience and minimal adverse effect profile make SSRIs an alternative to previously used behavior modalities and older pharmacologic agents and have the potential to improve the quality of life for men with premature ejaculation and their partners.
Serotonin and premature ejaculation: from physiology to patient management.
TLDR
Emerging clinical evidence indicates chronic and on-demand dosing of SSRIs has a beneficial effect for the treatment of men with PE, at least for paroxetine.
Buspirone treatment of sexual dysfunction associated with selective serotonin re‐uptake inhibitors
TLDR
The results suggest adjunctive buspirone may be useful in the management of sexual dysfunction associated with SSRIs; possible mechanisms of action are discussed.
...
1
2
3
...